Think of your cardiovascular system as a city that never closes.
Blood vessels are the roads, blood is the traffic, and every second of the day, nutrients, oxygen, hormones, and other passengers are moving through the network. When the roads are open and traffic flows normally, the whole city works quietly in the background.
But two very different problems can complicate the picture: buildup inside the road itself, and a clot that suddenly interferes with traffic.
That distinction is important when talking about nattokinase.
This enzyme, traditionally associated with natto, a fermented soybean food from Japan, has attracted attention for its relationship with fibrinolysis, blood clotting, blood pressure, and circulation. But does nattokinase actually remove arterial plaque? The answer requires a little more nuance.
What Is Nattokinase?
Nattokinase is an enzyme produced during the fermentation of soybeans by Bacillus subtilis. It is one of the compounds responsible for the growing scientific interest in natto and its potential cardiovascular effects.
Unlike nutrients such as vitamin C or magnesium, nattokinase is an enzyme with activity that researchers study in relation to fibrinolysis—the process involved in breaking down fibrin, a protein that helps form blood clots.
That gives nattokinase a particularly interesting place in cardiovascular wellness.
However, “supports fibrinolysis” and “clears arterial plaque” are not interchangeable claims.
Understanding that difference is the first step toward using the term nattokinase responsibly.
Arterial Plaque vs. Blood Clots: Why the Difference Matters
Imagine a highway with two separate problems.
The first is construction material slowly accumulating along the edge of the road. The second is a truck suddenly blocking a lane.
They are both traffic problems, but they are not the same problem.
Arterial plaque refers to atherosclerotic buildup within artery walls. It can contain cholesterol, fats, calcium, inflammatory cells, and other substances. Over time, plaque can affect the structure and flexibility of arteries.
A blood clot is different. It involves a mass formed through the blood-clotting process.
Nattokinase research is particularly interesting because of its fibrinolytic and antithrombotic activity. Reviews have described potential effects involving clot breakdown, platelet activity, blood pressure, and other cardiovascular pathways. However, much of the evidence remains preliminary, and nattokinase should not be treated as an established therapy for reversing atherosclerosis.
That distinction makes the conversation much more useful.
So, Can Nattokinase Remove Arterial Plaque?
This is probably the most important question.
The short answer is: there is not enough clinical evidence to say that nattokinase can reliably remove established arterial plaque in people.
Some laboratory and animal research has explored nattokinase in relation to atherosclerosis, lipid metabolism, and vascular health. These findings help explain why researchers are interested in the enzyme, but laboratory activity does not automatically translate into plaque reversal in humans.
In other words, nattokinase should not be presented as a natural “plaque remover.”
Instead, its potential role is better understood around circulation, fibrinolytic activity, and cardiovascular risk factors.
That may sound like a smaller claim, but it is actually a more scientifically useful one.
What Does Nattokinase Have to Do With Circulation?
Now we get to the part that makes nattokinase especially interesting.
Healthy circulation depends on a delicate balance. Blood needs to remain fluid enough to move through vessels, while the body also needs the ability to form clots when bleeding occurs.
Fibrinolysis is part of that balancing act.
Nattokinase has demonstrated fibrinolytic activity in experimental research, which is one reason it has been investigated as a potential cardiovascular-support compound.
Human research has also produced interesting findings.
In one randomized, double-blind, placebo-controlled study involving adults with elevated blood pressure, daily nattokinase supplementation was associated with reductions in systolic and diastolic blood pressure over eight weeks.
Another randomized controlled trial involving 86 participants reported modest reductions in both systolic and diastolic blood pressure after eight weeks of nattokinase supplementation.
These findings do not prove that nattokinase prevents heart attacks or clears plaque. They do, however, help explain why researchers continue to investigate its potential role in cardiovascular wellness.
Why the Natto Connection Matters
Nattokinase did not come out of nowhere.
It is associated with natto, a traditional Japanese food made by fermenting soybeans. During fermentation, Bacillus subtilis produces nattokinase and other compounds that have attracted scientific attention.
That traditional food connection is one reason nattokinase has such an unusual story compared with many modern supplements.
A food that has been part of Japanese cuisine for generations became the starting point for research into an enzyme with measurable biological activity.
It is a good reminder that sometimes the most interesting nutrition stories begin in ordinary kitchens rather than laboratories.
What Does 100 mg Actually Mean?
When looking at a nattokinase supplement, milligrams are only part of the story.
Enzyme activity is also commonly expressed in fibrinolytic units, or FU.
For example, NOW Foods Nattokinase 100 mg provides 100 mg of nattokinase with 2,000 FU of activity per capsule. The product is derived from non-GMO soy and is designed to support normal blood flow and cardiovascular health.
That is an important distinction for shoppers.
Two products could contain similar milligram amounts while having different enzyme activity. Looking at both the amount and the activity level provides a clearer picture of what is actually being offered.
You can explore the product here: NOW Foods Nattokinase 100 mg 120 Veg Capsules
What Nattokinase May Support
Rather than thinking about nattokinase as a one-purpose supplement, it makes more sense to consider the areas researchers have explored.
Normal Blood Flow
NOW Foods positions nattokinase as a supplement for maintaining normal blood flow. Its fibrinolytic activity is one reason this enzyme has attracted attention in circulation research.
Cardiovascular Wellness
Research has examined nattokinase in connection with blood pressure and several cardiovascular pathways. Human trials have reported reductions in blood pressure, although studies have generally been relatively small and short.
Healthy Clotting Balance
Nattokinase is particularly interesting because of its relationship with fibrinolysis and thrombotic processes. But this does not mean it should replace prescribed anticoagulant or antiplatelet therapy.
That last point deserves special attention.
Is Nattokinase Safe for Everyone?
No supplement that influences blood-clotting pathways should be treated casually.
NOW Foods specifically advises against using its nattokinase product with blood-thinning medications such as aspirin, warfarin, or heparin. It also cautions against use by people with ongoing bleeding or coagulation problems and recommends medical guidance for certain health conditions.
This matters because “natural blood flow support” can sound harmless when, biologically, the subject is much more complicated.
If you take anticoagulants or antiplatelet drugs, have a bleeding disorder, have recently undergone surgery or experienced significant trauma, or have another condition affecting clotting, speak with a healthcare professional before considering nattokinase.
And nattokinase should never be used as a substitute for prescribed cardiovascular treatment.
A Smarter Way to Think About Arterial Health
Here is the bigger picture.
If arterial plaque is the concern, the goal should not be to find one capsule that supposedly scrubs arteries clean.
Cardiovascular health is influenced by many factors, including blood pressure, cholesterol, smoking, physical activity, diet, blood glucose, body weight, sleep, and genetics.
Nattokinase may be an interesting addition to a broader wellness strategy, particularly for people interested in circulation and the science of fibrinolysis.
But it belongs in the supporting cast—not in the role of the entire medical team.
The Bottom Line
Nattokinase is one of the more unusual cardiovascular supplements because its story begins with fermented soybeans and leads into modern research on fibrinolysis, blood pressure, and circulation.
Current evidence gives researchers reasons to study its potential cardiovascular benefits, but it does not establish nattokinase as a proven treatment for removing arterial plaque.
The more accurate takeaway is this:
Nattokinase may support normal circulation and has demonstrated interesting fibrinolytic activity, while its potential effects on broader cardiovascular health continue to be studied.
So if you are curious about nattokinase for arterial plaque and circulation, look beyond the phrase “plaque remover.”
The more meaningful question is whether a supplement has a plausible mechanism, human evidence, a clearly stated activity level, and a safety profile that fits your situation.
Sometimes, better cardiovascular decisions begin by making the question more precise.